Prescription of Antibiotics for Periodontal Disease among Dentists in the Region of Tirana
DOI:
https://doi.org/10.3889/oamjms.2018.300Keywords:
Antibiotics, Dental prescriptions, PeriodontitisAbstract
BACKGROUND: Periodontal disease has been and will be a challenge for dentists in the entirety of oral pathologies. To date, there is no data regarding the prescription of antibiotics for periodontitis in the district of Tirana.
AIM: Evaluate aspects related to the pattern of prescription of antibiotics among dentists in Tirana region for periodontitis.
METHODS: Prescriptions from dental practitioners were collected from 25 pharmacies, randomly selected. The only prescription containing a diagnosis of periodontitis, with at least one antibiotic given, was included in the study. Data analysis was done with SPSS 20.
RESULTS: Out of 1159 initial prescriptions, only 314 met the selection criteria. The average age of patients was 39.91 ± 15.21 years. Mean duration of therapies was 5.57 ± 1.5 days. The most common form of prescription was one broad-spectrum antibiotic (74.5%), combined antibiotics therapy (22.3%) and narrow-spectrum antibiotic (3.2%). Combined antibiotics involved the use of Metronidazole with Amoxicillin (12.1%) and Metronidazole with Spiramycin (10.2%). Significant differences in the patterns of prescription were identified in relation with patient age and therapy duration (P < 0.05). No statistical difference was found in the patient’s gender and the typology of the therapy (P > 0.05).
CONCLUSIONS: Our study shows prescription characteristics of antibiotics for periodontal disease by dentists in Tirana for the first time. Amoxycillin is the most prescribed antibiotic, followed by amoxicillin with clavulanic acid. We found variation in dosage, frequency and duration for all antibiotics used, and perceptible discrepancies between observed and recommended practice. Guidelines on rational antibiotic use are needed for dental practitioners in Tirana and the Republic of Albania for better management of periodontitis and resistance prevention.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Shaikh HFM, Patil SH, Pangam TS, Rathod KV. Polymicrobial synergy and dysbiosis: An overview. J Indian Soc Periodontol. 2018; 22(2):101-106. https://doi.org/10.4103/jisp.jisp_385_17 PMid:29769762 PMCid:PMC5939015
Shi M, Wei Y, Hu W, Nie Y, Wu X, Lu R. The Subgingival Microbiome of Periodontal Pockets With Different Probing Depths in Chronic and Aggressive Periodontitis: A Pilot Study. Front Cell Infect Microbiol. 2018; 8:124. https://doi.org/10.3389/fcimb.2018.00124 PMid:29765908 PMCid:PMC5938363
Feng Z, Weinberg A. Role of bacteria in health and disease of periodontal tissues. Periodontology 2000. 2006; 40(1):50-76. https://doi.org/10.1111/j.1600-0757.2005.00148.x PMid:16398685
Simón-Soro A, Tomás I, Cabrera-Rubio R, Catalan MD, Nyvad B, Mira A. Microbial geography of the oral cavity. J Dent Res. 2013; 92(7):616-21. https://doi.org/10.1177/0022034513488119 PMid:23674263
Slots J, Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontology 2000. 1999; 20(1):82-121. https://doi.org/10.1111/j.1600-0757.1999.tb00159.x PMid:10522224
Van der Velden U. What exactly distinguishes aggressive from chronic periodontitis: is it mainly a difference in the degree of bacterial invasiveness? Periodontol 2000. 2017; 75(1):24-44 https://doi.org/10.1111/prd.12202 PMid:28758297
Lang NP, Lindhe J, editors. Clinical periodontology and implant dentistry, 2 Volume Set. John Wiley & Sons, 2015.
Seiler SJ, Herold WR. The use of systemic antibiotics in the treatment of aggressive periodontal disease. Gen Dent Periodont. 2005.
Blair FM, Chapple IL. Prescribing for periodontal disease. Prim Dent J. 2014; 3(4):38-43. https://doi.org/10.1308/205016814813877234 PMid:25668374
Duffau F, Bensahel JJ, Blanchard P, Cohen R, Descroix V, et al. Agence française de sécurité sanitaire des produits de santé AFSSAPS. Prescription of antibiotics for oral and dental care. Med Mal Infect. 2012; 42(5):193-202. https://doi.org/10.1016/j.medmal.2011.12.004 PMid:22503659
Mombelli A, Décaillet F, Almaghlouth A, Wick P, Cionca N. Efficient, minimally invasive periodontal therapy. An evidence-based treatment concept. Schweiz Monatsschr Zahnmed. 2011; 121(2):145-57. PMid:21344327
The American Academy of Periodontology (position paper), Systemic antibiotics in periodontics. J Periodontol. 2004; 75:1553-1565. https://doi.org/10.1902/jop.2004.75.11.1553
Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017; 3:17038. https://doi.org/10.1038/nrdp.2017.38 PMid:28805207
Herrera D, Alonso B, León R,. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol. 2008; 35:45-66. https://doi.org/10.1111/j.1600-051X.2008.01260.x PMid:18724841
Ciancio SG. Systemic medications: Clinical significance in periodontics. J Clin Periodontol. 2002; 29(Suppl 2):17-21. https://doi.org/10.1034/j.1600-051X.29.s2.3.x PMid:12087965
Rajendra A, Spivakovsky S. Antibiotics in aggressive periodontitis, is there a clinical benefit?. Evidence-based dentistry. 2016; 17(4):100. https://doi.org/10.1038/sj.ebd.6401197 PMid:27980332
Weinstein L. Antimicrobial agents. The pharmacological basis of therapeutics. 1975:1201-23.
Usin MM, Tabares SM, Menso J, de Albera ER, Sembaj A. Generalized aggressive periodontitis: microbiological composition and clinical parameters in non-surgical therapy. Acta Odontol Latinoam. 2016; 29(3):255-261. PMid:28383606
Rams TE, Dujardin S, Sautter JD, Degener JE, Van Winkelhoff AJ. Spiramycin resistance in human periodontitis microbiota. Anaerobe. 2011; 17(4):201-5. https://doi.org/10.1016/j.anaerobe.2011.03.017 PMid:21524712
Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontology 2000. 2016; 71(1):82-112. https://doi.org/10.1111/prd.12121 PMid:27045432
Chiappe V, Gómez M, Fernández-Canigia L, Romanelli H. The effect of spiramycin on Porphyromonas gingivalis and other "classic" periopathogens. Acta Odontol Latinoam. 2011; 24(1):115-21. PMid:22010417
Rams TE, Slots J. Antibiotics in periodontal therapy: An update. Compend Contin Educ Dent.1992; 13:1130.
Dabija-Wolter G,2, Al-Zubaydi SS, Mohammed MMA, Bakken V, Bolstad AI. The effect of metronidazole plus amoxicillin or metronidazole plus penicillin V on periodontal pathogens in an in vitro biofilm model. Clin Exp Dent Res. 2018; 4(1):6-12. https://doi.org/10.1002/cre2.96 PMid:29744209 PMCid:PMC5813892
Jorgensen MG, Slots J. Practical antimicrobial periodontal therapy. Compendium of continuing education in dentistry (Jamesburg, NJ: 1995). 2000; 21(2):111-4.
Prakasam A, Elavarasu SS, Natarajan RK. Antibiotics in the management of aggressive periodontitis. Journal of pharmacy & bioallied sciences. 2012; 4(Suppl 2):S252. https://doi.org/10.4103/0975-7406.100226 PMid:23066264 PMCid:PMC3467876
Mombelli A, Almaghlouth A, Cionca N, Cancela J, Courvoisier DS, Giannopoulou C. Microbiologic Response to Periodontal Therapy and Multivariable Prediction of Clinical Outcome. J Periodontol. 2017; 88(12):1253-1262. https://doi.org/10.1902/jop.2017.170286 PMid:28844191
Harks I, Koch R, Eickholz P, Hoffmann T, Kim TS, Kocher T, et al. Is progression of periodontitis relevantly influenced by systemic antibiotics? A clinical randomized trial. J Clin Periodontol. 2015; 42(9):832-42. https://doi.org/10.1111/jcpe.12441 PMid:26250060 PMCid:PMC5054899
Mombelli A, Cionca N, Almaghlouth A, Décaillet F, Courvoisier DS, Giannopoulou C. Are there specific benefits of amoxicillin plus metronidazole in Aggregatibacter actinomycetemcomitans-associated periodontitis? Double-masked, randomized clinical trial of efficacy and safety. J Periodontol. 2013; 84(6):715-24. https://doi.org/10.1902/jop.2012.120281 PMid:22873656
Akrivopoulou C, Green IM, Donos N, Nair SP, Ready D. Aggregatibacter actinomycetemcomitans serotype prevalence and antibiotic resistance in a UK population with periodontitis. J Glob Antimicrob Resist. 2017; 10:54-58. https://doi.org/10.1016/j.jgar.2017.03.011 PMid:28668698
Alamanda M, Denthumdas SK, Wadgave U, Pharne PM, Patil SJ, Kondreddi S, Deshpande P, Koppikar RS. Comparative Evaluation of Ciprofloxacin Levels in GCF and Plasma of Chronic Periodontitis Patients: Quasi Experimental Study. J Clin Diagn Res. 2016; 10(6):ZC47-50. https://doi.org/10.7860/JCDR/2016/18446.7987
Müller HP, Holderrieth S, Burkhardt U, Höffler U. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J Clin Periodontol. 2002; 29(8):736-42. https://doi.org/10.1034/j.1600-051X.2002.290810.x PMid:12390570
Eguchi T, Shimizu Y, Furuhata K, Fukuyama M. Antibacterial activity of new-quinolone and macrolide antibiotics against oral bacteria. Kansenshogaku Zasshi. 2002; 76(11):939-45. https://doi.org/10.11150/kansenshogakuzasshi1970.76.939 PMid:12508477
Reeves BD, Young M, Grieco PA, Suci P. Aggregatibacter actinomycetemcomitans biofilm killing by a targeted ciprofloxacin prodrug. Biofouling. 2013; 29(8):1005-14. https://doi.org/10.1080/08927014.2013.823541 PMid:23952779 PMCid:PMC3818142
Suci P, Young M. Selective killing of Aggregatibacter actinomycetemcomitans by ciprofloxacin during development of a dual species biofilm with Streptococcus sanguinis. Arch Oral Biol. 2011; 56(10):1055-63. https://doi.org/10.1016/j.archoralbio.2011.03.013 PMid:21507381
Tezel A, Yucel O, Orbak R, Kara C, Kavrut F, Yagiz H, Sahin T. The gingival crevicular fluid ciprofloxacin level in subjects with gingivitis and periodontitis, and its effects on clinical parameters. J Periodontal Res. 2005; 40(5):395-400. https://doi.org/10.1111/j.1600-0765.2005.00820.x PMid:16105092
Ciancio SG. Systemic medications: clinical significance in periodontics. Journal of clinical periodontology. 2002; 29:14-8. https://doi.org/10.1034/j.1600-051X.29.s2.3.x
Cacchillo DA, Walters JD. Effect of ciprofloxacin on killing of Actinobacillus actinomycetemcomitans by polymorphonuclear leukocytes. Antimicrob Agents Chemother. 2002; 46(6):1980-4. https://doi.org/10.1128/AAC.46.6.1980-1984.2002 PMCid:PMC127222
Froum SJ, Weinberg MA. An Evaluation of Antibiotic Use in Periodontal and Implant Practices. Int J Periodontics Restorative Dent. 2015; 35(4):481-7. https://doi.org/10.11607/prd.2488 PMid:26133137
Oberoi SS, Dhingra C, Sharma G, Sardana D. Antibiotics in dental practice: how justified are we. Int Dent J. 2015; 65(1):4-10. https://doi.org/10.1111/idj.12146 PMid:25510967
Demirbas F, Gjermo PE, Preus HR. Antibiotic prescribing practices among Norwegian dentists. Acta Odontol Scand. 2006; 64(6):355-9. https://doi.org/10.1080/00016350600844394 PMid:17123912
Mainjot A, D'Hoore W, Vanheusden A, Van Nieuwenhuysen JP. Antibiotic prescribing in dental practice in Belgium. Int Endod J. 2009; 42(12):1112-7. https://doi.org/10.1111/j.1365-2591.2009.01642.x PMid:19912383
Al-Mubarak S, Al-Nowaiser A, Rass MA, Alsuwyed A, Alghofili A, Al-Mubarak EK, Ho A. Antibiotic prescription and dental practice within Saudi Arabia; the need to reinforce guidelines and implement specialty needs. J Int Acad Periodontol. 2004; 6(2):47-55. PMid:15125015
Vessal G, Khabiri A, Mirkhani H, Cookson BD, Askarian M. Study of antibiotic prescribing among dental practitioners in Shiraz, Islamic Republic of Iran. East Mediterr Health J. 2011; 17(10):763-9. https://doi.org/10.26719/2011.17.10.763 PMid:22256411
Kandemir S, Ergül N. Grievances in cases using antibiotics due to orodental problems and assessment of the need for antibiotics. Int Dent J. 2000; 50(2):73-7. https://doi.org/10.1002/j.1875-595X.2000.tb00802.x PMid:10945185
WHO, Antimicrobial resistance: global report on surveillance 2014, Apr 2014. www.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
